Difference-in-Differences Regression Model Estimates of Changes in Out-of-Pocket Spending, Treatment Adherence, and Medical Claims for Diabetes-Related Complications Among All Insulin Users With Type 1 Diabetes by Insulin Type Overall and by Levels of Prepolicy Spending. The gene discussed is INS; the disease is diabetes mellitus.